Exhibit 8, 100416 Brazil FMD Risk Evaluation - R-Calf
Exhibit 8, 100416 Brazil FMD Risk Evaluation - R-Calf
Exhibit 8, 100416 Brazil FMD Risk Evaluation - R-Calf
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
provide CSFV-<strong>FMD</strong>V diagnostics. These individuals have been working at the<br />
laboratory for at least 10 years.<br />
The laboratory is old but well maintained and reasonably equipped.<br />
The site visit team found the laboratory personnel highly qualified and motivated. The<br />
team also found that they have the equipment necessary to detect disease.<br />
The turnaround time for results is excellent, avoiding the extension of quarantine time on<br />
farms and States affected by an epidemiological alert.<br />
The laboratory has SOPs (standard operating procedures) and QA (quality assurance)<br />
control for, at least, the two tests the site visit team scrutinized. The procedures for<br />
CSFV and <strong>FMD</strong>V diagnosis are well established and are suited for both detection and<br />
confirmation of the etiologic agent. They are:<br />
o <strong>FMD</strong>V: Surveillance and transport certificates and sera samples are sent to<br />
accredited laboratories in Rio Grande do Sul, Sao Paulo, Minas Gerais and Mato<br />
Grosso. Inconclusive ELISA/ITB results go to Recife. If a clinical case is reported,<br />
the DSA direct that the samples be sent to LANAGRO to perform VIAA or ELISA<br />
3ABC/EITB. If a case ends up with suspected positive results, an alert is sent to the<br />
DSA and CGAL (General Coordination for Animal Laboratories) authorities who in<br />
turn will implement their control and eradication policies.<br />
o CSFV: The same accredited laboratories perform ELISA for CSFV antibodies in<br />
sera. Any serum-positive or inconclusive result is sent to LANAGRO-Recife for<br />
confirmation. If a clinical case is reported, the samples go to LANAGRO-Recife<br />
only, where VIAA, virus neutralization, and/or ELISA are performed. If the result is<br />
confirmed as positive, the authorities take the appropriate measures for control and<br />
eradication.<br />
Conclusions:<br />
APHIS concludes that <strong>Brazil</strong> has the diagnostic capability to adequately test samples for the<br />
presence of the <strong>FMD</strong>, CSF, SVD, and ASF virus. The laboratories in Pedro Leopoldo, Pará, and<br />
Recife have adequate diagnostic capabilities to test samples for the <strong>FMD</strong> virus, including adequate<br />
quality control activities, laboratory equipment, and sufficient staff. The Recife laboratory has<br />
adequate diagnostic capabilities to test samples for <strong>FMD</strong> and other swine notifiable diseases. The<br />
tests used to investigate evidence of viral activity are consistent with OIE guidelines. The staff<br />
members at the facilities visited in 2002 and 2008 were well trained and motivated. The laboratories<br />
have sufficient quality control activities, routinely monitor and calibrate laboratory equipment, have<br />
sufficient staff, have an effective and efficient recordkeeping system for storage and retrieval of data,<br />
and turn samples around quickly.<br />
11. Policies and infrastructure for animal disease control in the region<br />
Each country should have contingency plans in place to limit any disease outbreak. In this section<br />
we provide an overview of the elements of Santa Catarina’s emergency plan if suspect cases of<br />
<strong>FMD</strong>, CSF, SVD, and ASF are identified.<br />
The <strong>Brazil</strong>ian government has developed a Federal contingency plan for <strong>FMD</strong> and CSF. Each State<br />
also drafts a specific contingency plan for immediate, effective action in an emergency. Each State<br />
APHIS <strong>Evaluation</strong> of the Status of the <strong>Brazil</strong>ian State of Santa Catarina 57